A novel variant of FGFR3 causes proportionate short stature

Sarina G. Kant, Iveta Cervenkova, Lukas Balek, Lukas Trantirek, Gijs WE Santen, Martine C. De Vries, Hermine A. Van Duyvenvoorde, Michiel J.R. Van Der Wielen, Annemieke J.M.H. Verkerk, André G. Uitterlinden, Sabine E. Hannema, Jan M. Wit, Wilma Oostdijk, Pavel Krejci, Monique Losekoot

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Scopus)


Objective: Mutations of the fibroblast growth factor receptor 3 (FGFR3) cause various forms of short stature, of which the least severe phenotype is hypochondroplasia, mainly characterized by disproportionate short stature. Testing for an FGFR3 mutation is currently not part of routine diagnostic testing in children with short stature without disproportion. Design: A three-generation family A with dominantly transmitted proportionate short stature was studied by whole-exome sequencing to identify the causal gene mutation. Functional studies and protein modeling studies were performed to confirm the pathogenicity of the mutation found in FGFR3. We performed Sanger sequencing in a second family B with dominant proportionate short stature and identified a rare variant in FGFR3. Methods: Exome sequencing and/or Sanger sequencing was performed, followed by functional studies using transfection of the mutant FGFR3 into cultured cells; homology modeling was used to construct a three-dimensional model of the two FGFR3 variants. Results: A novel p.M528I mutation in FGFR3 was detected in family A, which segregates with short stature and proved to be activating in vitro. In family B, a rare variant (p.F384L) was found in FGFR3, which did not segregate with short stature and showed normal functionality in vitro compared with WT. Conclusions: Proportionate short stature can be caused by a mutation in FGFR3. Sequencing of this gene can be considered in patients with short stature, especially when there is an autosomal dominant pattern of inheritance. However, functional studies and segregation studies should be performed before concluding that a variant is pathogenic.

Original languageEnglish
Pages (from-to)763-770
Number of pages8
JournalEuropean journal of endocrinology
Issue number6
Publication statusPublished - 1 Jun 2015

Cite this